Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.99 USD | -1.96% | +9.11% | -7.13% |
12:17pm | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 16 | Foghorn Therapeutics Names Kristian Humer CFO | MT |
Financials (USD)
Sales 2024 * | 35.28M | Sales 2025 * | 37.33M | Capitalization | 255M |
---|---|---|---|---|---|
Net income 2024 * | -247M | Net income 2025 * | -221M | EV / Sales 2024 * | 4.5 x |
Net cash position 2024 * | 96.34M | Net cash position 2025 * | 227M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
-1.48
x | P/E ratio 2025 * |
-2.35
x | Employees | 116 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.21% |
Latest transcript on Foghorn Therapeutics Inc.
1 day | -1.96% | ||
1 week | +9.11% | ||
Current month | +9.71% | ||
1 month | -15.63% | ||
3 months | +112.41% | ||
6 months | +56.40% | ||
Current year | -7.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 17-04-30 | |
Douglas Cole
FOU | Founder | 63 | 15-09-30 |
Fanny Cavalié
COO | Chief Operating Officer | 46 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Simba Gill
BRD | Director/Board Member | 60 | 17-06-30 |
Douglas Cole
FOU | Founder | 63 | 15-09-30 |
B. Parshall
BRD | Director/Board Member | 70 | 22-08-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 5.99 | -1.96% | 48,320 |
24-05-02 | 6.11 | +4.27% | 68,642 |
24-05-01 | 5.86 | +7.33% | 60,654 |
24-04-30 | 5.46 | -4.71% | 28,866 |
24-04-29 | 5.73 | +4.37% | 16,463 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.13% | 255M | |
+8.96% | 105B | |
-1.43% | 104B | |
+5.21% | 22.94B | |
-12.15% | 22.34B | |
-6.73% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- FHTX Stock